Clinical trial Recruiting at 2 sites Interventional Ages 60 and up

Using a smartphone app to help older adults with mild cognitive impairment take their blood pressure medications

Official title: Digital Technology to Support Adherence to Hypertension Medications for Older Adults With Mild Cognitive Impairment

Run by University of Arizona · NCT06307574 · Data updated 2026-11-12

This study is testing whether a smartphone app that sends medication reminders can help older adults with mild cognitive impairment take their blood pressure medications more regularly.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Arizona
Academic / other
Locations2 sites (Tucson, Arizona and 1 other locations)
StatusRecruiting
StartedFebruary 29, 2024
Main results expectedApril 30, 2026
Study endsApril 30, 2026
Registry record updatedOctober 15, 2025
Trial IDNCT06307574 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are community-dwelling older adults aged 60 and above who experience mild cognitive impairment and are capable of managing at least one prescribed antihypertensive medication.

Probably not a fit

Patients with a diagnosis of dementia or those living in assisted living or skilled nursing facilities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The bpMedManage project aims to evaluate the effectiveness of a smartphone application designed to enhance medication adherence among older adults with mild cognitive impairment over a 16-week period. The study will involve 100 participants who will be randomly assigned to one of two groups: one receiving medication reminders and educational content through the app, and the other receiving only educational content. Both groups will undergo baseline assessments and medication adherence monitoring for four weeks. The goal is to determine if the app can significantly improve adherence to antihypertensive medications in this population.

Why it matters

Potential benefit: If successful, this intervention could lead to improved management of hypertension in older adults, potentially reducing health complications associated with poor medication adherence.

How similar studies have gone: Other studies have shown promise in using digital health interventions to improve medication adherence, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 60+
2. Community-dwelling older adults
3. Self-reported fluent in English
4. Adequate self-reported visual and hearing ability
5. Self-reported memory, thinking, or concentration challenges
6. Self-manage at least one prescribed antihypertensive medication
7. Have and use a smartphone
8. No self-reported history of major depression or other mental health diagnoses
9. No self-reported diagnosis of dementia or other neurological disorder such as stroke, TBI, and Parkinson's disease
10. TICS-M score between 27-37 and Montreal Cognitive Assessment (MoCA) score between 20-26
11. Willing to participate in the study for at least 4 months

Exclusion Criteria:

1. Diagnosis of dementia
2. Lives in assisted living facility or skilled nursing facility

Where it's running

  • University of Arizona
    Tucson, Arizona, United States
    Recruiting
  • University of Illinois, Urbana-Champaign
    Champaign, Illinois, United States
    Recruiting

Study contacts

  • Principal investigator: Kathleen Insel, PhD — University of Arizona
  • Study coordinator: Kathleen Insel, PhD
  • Email: insel@arizona.edu
  • Phone: 520-626-6220

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.